Klin Padiatr 2020; 232(03): e4
DOI: 10.1055/s-0040-1709775
DOI: 10.1055/s-0040-1709775
Abstracts
Enhancer hijacking on the MYCN amplicon in neuroblastoma
Autor*innen
-
K Helmsauer
1 Department of Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin, Berlin -
M Valieva
2 RG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany -
S Ali
2 RG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany -
R Chamorro Gonzalez
1 Department of Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin, Berlin -
R Schöpflin
2 RG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany -
JH Schulte
1 Department of Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin, Berlin -
S Mundlos
2 RG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany -
RP Koche
3 Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, USA -
AG Henssen
1 Department of Pediatric Oncology and Hematology, Charité – Universitätsmedizin Berlin, Berlin
